Design Therapeutics SG&A Expense (TTM) Insights

Design Therapeutics Inc (DSGN)

3.35 0.00 (0.00%) USD | NASDAQ | Jun 28, 16:00

3.32 -0.03 (-0.90%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
March 31, 2024	19.80M
December 31, 2023	21.13M
September 30, 2023	22.16M
June 30, 2023	21.48M
March 31, 2023	20.29M
December 31, 2022	18.98M
September 30, 2022	17.63M

Date	Value
June 30, 2022	15.54M
March 31, 2022	13.86M
December 31, 2021	11.05M
September 30, 2021	8.449M
June 30, 2021	6.14M
March 31, 2021	3.913M
December 31, 2020	2.496M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

2.496M

Minimum

Dec 2020

22.16M

Maximum

Sep 2023

14.49M

Average

16.59M

Median

SG&A Expense (TTM) Benchmarks